- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 409/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 409/00
Total number of patents in this class: 176
10-year publication summary
|
13
|
6
|
2
|
1
|
3
|
2
|
3
|
3
|
0
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3751 |
8 |
| Theravance Biopharma R&D IP, LLC | 456 |
5 |
| Janssen Pharmaceutica N.V. | 3394 |
4 |
| Gilead Sciences, Inc. | 2032 |
4 |
| Hoffmann-La Roche Inc. | 3439 |
3 |
| LG Chem, Ltd. | 17635 |
3 |
| Syngenta Participations AG | 1904 |
3 |
| Bayer Cropscience AG | 2040 |
3 |
| Abbvie Inc. | 1800 |
3 |
| Northwestern University | 3398 |
3 |
| Bristol-myers Squibb Company | 4880 |
2 |
| Merck Patent GmbH | 5815 |
2 |
| Allergan, Inc. | 2347 |
2 |
| Centre National de La Recherche Scientifique | 10464 |
2 |
| Sumitomo Chemical Company, Limited | 9043 |
2 |
| Bridge Pharma, Inc. | 33 |
2 |
| Cambridge Display Technology Limited | 496 |
2 |
| Eli Lilly and Company | 3848 |
2 |
| The Hong Kong University of Science and Technology | 754 |
2 |
| Hutchison MediPharma Enterprises Limited | 14 |
2 |
| Other owners | 117 |